SECURITIES AND EXCHANGE COMMISSION

 

Washington, D. C.  20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

 

April 30, 2003

 

Date of Report (date of earliest event reported)

 

NANOGEN, INC.

(Exact name of Registrant as specified in charter)

 

Delaware

 

000-23541

 

33-0489621

(State or other jurisdiction of
incorporation)

 

(Commission File Number)

 

(I. R. S.  Employer Identification No.)

 

 

10398 Pacific Center Court
San Diego, California 92121

(Address of principal executive offices)

 

Registrant’s telephone number, including area code:  (858) 410-4600

 

N/A

(Former name or former address, if changed since last report)

 

 



 

Item 9.

 

Regulation FD Disclosure and Item 12. Results of Operations and Financial Condition

 

 

 

 

 

On April 30, 2003, we issued a press release announcing results for our fiscal quarter ended March 31, 2003.

 

 

 

 

 

A copy of the press release is attached hereto as Exhibit 99.1.

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date:  April 30, 2003

 

NANOGEN, INC.

 

 

 

 

 

 

/s/ HOWARD C. BIRNDORF

 

 

Howard C. Birndorf

 

 

Chief Executive Officer

 

2